• Mashup Score: 0

    Dr. Sitra Tauscher-Wisniewski, from Novartis Gene Therapies, discusses long-term data for onasemnogene abeparvovec (Zolgensma), an FDA-approved gene therapy for SMA.

    Tweet Tweets with this article
    • Sitra Tauscher-Wisniewski, MD, Vice President of Clinical Development & Analytics at Novartis Gene Therapies, discusses long-term data for onasemnogene abeparvovec (Zolgensma), an FDA-approved gene therapy for spinal muscular atrophy #SMA @SMA_UK_ https://t.co/T7qSPC26Mi

  • Mashup Score: 0

    Dr. Sitra Tauscher-Wisniewski, from Novartis Gene Therapies, discusses the importance of early diagnosis of spinal muscular atrophy (SMA).

    Tweet Tweets with this article
    • Sitra Tauscher-Wisniewski, MD, Vice President of Clinical Development & Analytics at Novartis Gene Therapies, discusses the importance of early spinal muscular atrophy #SMA diagnosis #checkrare #rarediseases @SMA_UK_ https://t.co/OS6miI4WZT

  • Mashup Score: 0

    Dr. Sitra Tauscher-Wisniewski, from Novartis Gene Therapies, discusses the importance of early diagnosis of spinal muscular atrophy (SMA).

    Tweet Tweets with this article
    • Sitra Tauscher-Wisniewski, MD, Vice President of Clinical Development & Analytics at Novartis Gene Therapies, discusses the importance of early spinal muscular atrophy #SMA diagnosis #checkrare #rarediseases @SMA_UK_ https://t.co/OS6miI4WZT

  • Mashup Score: 0

    As Dr. Diane Castro explains, the number of copies of the presence SMN2 gene play an important role in the severity of the SMA symptoms.

    Tweet Tweets with this article
    • Diana Castro, MD, founder of the Neurology Rare Disease Center in Dallas, Texas, discusses the pathophysiology of spinal muscular atrophy #SMA @SMA_UK_ #neurologyrarediseasecenter #rarediseases https://t.co/XyH1uAG4wk

  • Mashup Score: 0

    SMA is a progressive disorder. The sooner a person with SMA can be diagnosed and be given proper treatment, the better their chances of maintaining a certain level of activity and quality of life.

    Tweet Tweets with this article
    • Founder of the Neurology Rare Disease Center in Dallas, Texas, Diana Castro, MD, discusses newborn screening for spinal muscular atrophy #SMA in the United States. https://t.co/kbwiJA0I91

  • Mashup Score: 0

    Dr. Sitra Tauscher-Wisniewski, from Novartis Gene Therapies, discusses the importance of early diagnosis of spinal muscular atrophy (SMA).

    Tweet Tweets with this article
    • Sitra Tauscher-Wisniewski, MD, Vice President of Clinical Development & Analytics at Novartis Gene Therapies, discusses the importance of early spinal muscular atrophy #SMA diagnosis #checkrare #rarediseases @SMA_UK_ https://t.co/OS6miI4WZT

  • Mashup Score: 1

    SMA is a progressive disorder. The sooner a person with SMA can be diagnosed and be given proper treatment, the better their chances of maintaining a certain level of activity and quality of life.

    Tweet Tweets with this article
    • Founder of the Neurology Rare Disease Center in Dallas, Texas, Diana Castro, MD, discusses newborn screening for spinal muscular atrophy #SMA in the United States. https://t.co/kbwiJA0I91

  • Mashup Score: 0

    Dr. Diana Castro discusses the most common early symptoms observed in children with different types of spinal muscular atrophy (SMA).

    Tweet Tweets with this article
    • Diana Castro, MD, founder of the Neurology Rare Disease Center in Dallas, Texas, discusses the most common early symptoms observed in the different types of spinal muscular atrophy (SMA). https://t.co/CIqJbf5VZw @SMA_UK_ @ACTforSMA #raredisease #neurology #SMA #DianaCastro